Responder ao apelo para resolver a pandemia do COVID-19Por trás de cada profissional de laboratório, está o apoio de 53.000 Healthineers

A urgência e a complexidade da situação atual do COVID-19 continuam a crescer e os laboratórios desempenham um papel essencial. Os testes para SARS-CoV-2 não são a única necessidade no tratamento de pacientes com COVID-19. A triagem e a monitorização rápidas e precisas para a variedade de problemas de saúde que podem surgir através da doença COVID-19 também são necessárias.

SARS-CoV-2 virus rendering

We are committed to helping laboratorians navigate this new world, in order to help you provide the best care to patients in this challenging time. A new COVID-19 Laboratory Testing Guide provides timely, relevant content to support the extended role of laboratory diagnostics in managing COVID-19 patients:

  • Transmission and clinical classification
  • Course of patients at risk
  • Current recommendations for laboratory testing
  • Frequent laboratory abnormalities
  • Impact of patients with co-morbidities

At Siemens Healthineers, we are fully committed to supporting our partners throughout the healthcare system by helping them deliver high-value care to patients.


As a truly emergent human pathogen, a specific test for presence of the virus did not exist with the onset of cases, necessitating rapid development. Most current testing for infection relies on detection of the viral RNA using a reverse-transcription polymerase chain reaction (rtPCR). In addition, serology testing from a blood sample can identify antibody to the virus.1,2 These tests will likely prove extremely valuable for surveillance and could potentially provide assessment for immunity, as well as aiding identification of acute infection.

As availability and supplies for molecular testing for COVID-19 increase, testing turn-around times should improve, but remain contingent on sample collection, proper preanalytical handling (RNA is highly degradable), time to test result, and access to testing (point-of-care vs. lab-based).


Randy Q. Cron, MD, PhD

In this webinar, Dr. Randy Cron will discuss criteria for identifying Cytokine storm syndrome (CSS) in patients, complications, and available treatments which include glucocorticoids, but also targeted therapies that dampen pro-inflammatory cytokines like interleukin-1 (IL-1) and IL-6.

Speaker:
Randy Q. Cron, MD, PhD
University of Alabama at Birmingham


Prof. Mario Plebani and Prof. Shu Kui Wang

Experiences and Population Management Strategies from Highly Affected Regions of China and Italy: Laboratory tests are vital throughout many clinical pathways, and this webinar describes how laboratory medicine can efficiently help combat the COVID-19 outbreak.

Speakers:
Prof. Mario Plebani
Professor of Clinical Biochemistry and Clinical Molecular Biology, University of Padova School of Medicine
Chief, Department of Laboratory Medicine, University Hospital, Padova, Italy

Prof. Shu Kui Wang
Vice Dean
Director of Central Laboratory
Nanjing First Hospital, Nanjing Medical University, Nanjing, China


COVID-19 Laboratory testing guide

Testing is critical to differentiate COVID-19 from other respiratory disease such as influenza or RSV (respiratory syncytial virus). Widespread testing will both inform a COVID-19 diagnosis and aid a greater understanding of disease prevalence, especially in infections that are asymptomatic.


COVID-19 Booklet - Patient brochure
  • What are the symptoms of COVID-19?
  • How does COVID-19 progress?
  • How to test for, treat, and immunize
  • How are COVID-19 tests administered?
  • How to avoid spreading COVID-19

Siemens Healthineers coagulation abnormalities testing guide

As part of our commitment to labs and clinicians in the fight against the pandemic, we aim to keep you informed on current coagulation testing and monitoring recommendations in COVID-19 patients. Read our eBook for an overview on:

  • Thrombosis risk factors
  • ISTH-recommended coagulation testing algorithm
  • Leading recommendations for anticoagulation treatment
  • Relevant parameters for patient monitoring

In this webinar, Dr. Randy Cron will discuss criteria for identifying Cytokine storm syndrome (CSS) in patients, complications, and available treatments which include glucocorticoids, but also targeted therapies that dampen pro-inflammatory cytokines like interleukin-1 (IL-1) and IL-6.

Speaker:
Randy Q. Cron, MD, PhD
University of Alabama at Birmingham

1

2